Anne Hudson Blaes

Summary

Affiliation: University of Minnesota
Country: USA

Publications

  1. ncbi Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial
    Anne H Blaes
    Department of Medicine, The University of Minnesota, Minneapolis, Minnesota 55455, USA
    Cancer 104:1661-7. 2005
  2. ncbi Cardiac complications from cancer therapy
    Anne Hudson Blaes
    Division of Hematology, Oncology, and Transplantation, University of Minnesota Medical Center, USA
    Minn Med 93:40-4. 2010
  3. ncbi Post-transplant lymphoproliferative disorders following solid-organ transplantation
    Anne H Blaes
    University of Minnesota, Department of Hematology Oncology Transplantation, 420 Delaware Street S E, Minneapolis, MN 55455, USA
    Expert Rev Hematol 3:35-44. 2010
  4. ncbi Pathologic femur fractures after limb-sparing treatment of soft-tissue sarcomas
    Anne H Blaes
    Department of Medicine, Division of Hematology Oncology Transplantation, University of Minnesota, 420 Delaware Street, S E, MMC 480, Minneapolis, MN 55455, USA
    J Cancer Surviv 4:399-404. 2010
  5. ncbi Positron emission tomography scanning in the setting of post-transplant lymphoproliferative disorders
    Anne H Blaes
    Division of Hematology Oncology Transplantation, Department of Medicine, University of Minnesota, Medicine, 420 Delaware Street, S E, MMC 480, Minneapolis, MN, USA
    Clin Transplant 23:794-9. 2009
  6. ncbi Angiotensin converting enzyme inhibitors may be protective against cardiac complications following anthracycline chemotherapy
    Anne H Blaes
    Department of Medicine, Division of Hematology Oncology Transplantation, University of Minnesota, 420 Delaware Street, S E, MMC 480, Minneapolis, MN 55455, USA
    Breast Cancer Res Treat 122:585-90. 2010
  7. ncbi Monitoring and preemptive rituximab therapy for Epstein-Barr virus reactivation after antithymocyte globulin containing nonmyeloablative conditioning for umbilical cord blood transplantation
    Anne H Blaes
    University of Minnesota Blood and Marrow Transplant Program, Minneapolis, Minnesota, USA
    Biol Blood Marrow Transplant 16:287-91. 2010
  8. ncbi Malassezia: is it a pulmonary pathogen in the stem cell transplant population?
    A H Blaes
    Division of Hematology Oncology Transplantation, Veterans Affairs Medical Center, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Transpl Infect Dis 11:313-7. 2009
  9. ncbi Necrotizing leukoencephalopathy following CHOP chemotherapy
    Anne H Blaes
    University of Minnesota, Department of Medicine, Division of Hematology Oncology Transplantation, United States
    Leuk Res 32:1611-4. 2008
  10. ncbi Quality of life appears similar between survivors of indolent and aggressive non-Hodgkin lymphoma
    Anne H Blaes
    Division of Hematology Oncology Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA
    Leuk Lymphoma 52:2105-10. 2011

Detail Information

Publications10

  1. ncbi Rituximab therapy is effective for posttransplant lymphoproliferative disorders after solid organ transplantation: results of a phase II trial
    Anne H Blaes
    Department of Medicine, The University of Minnesota, Minneapolis, Minnesota 55455, USA
    Cancer 104:1661-7. 2005
    ..Alternative treatments such as rituximab have been explored...
  2. ncbi Cardiac complications from cancer therapy
    Anne Hudson Blaes
    Division of Hematology, Oncology, and Transplantation, University of Minnesota Medical Center, USA
    Minn Med 93:40-4. 2010
    ..It also presents guidance for primary care providers caring for survivors who may be at risk of cardiovascular complications...
  3. ncbi Post-transplant lymphoproliferative disorders following solid-organ transplantation
    Anne H Blaes
    University of Minnesota, Department of Hematology Oncology Transplantation, 420 Delaware Street S E, Minneapolis, MN 55455, USA
    Expert Rev Hematol 3:35-44. 2010
    ..Efforts continue to be made to improve the outcome of patients with PTLD...
  4. ncbi Pathologic femur fractures after limb-sparing treatment of soft-tissue sarcomas
    Anne H Blaes
    Department of Medicine, Division of Hematology Oncology Transplantation, University of Minnesota, 420 Delaware Street, S E, MMC 480, Minneapolis, MN 55455, USA
    J Cancer Surviv 4:399-404. 2010
    ..Local control for sarcomas of the long bones includes limb sparing surgery and radiotherapy. While effective, there are potential complications...
  5. ncbi Positron emission tomography scanning in the setting of post-transplant lymphoproliferative disorders
    Anne H Blaes
    Division of Hematology Oncology Transplantation, Department of Medicine, University of Minnesota, Medicine, 420 Delaware Street, S E, MMC 480, Minneapolis, MN, USA
    Clin Transplant 23:794-9. 2009
    ..Post-transplant lymphoproliferative disorder (PTLD) is a serious complication of transplantation. We examined the role of positron emission tomography (PET) scanning in PTLD...
  6. ncbi Angiotensin converting enzyme inhibitors may be protective against cardiac complications following anthracycline chemotherapy
    Anne H Blaes
    Department of Medicine, Division of Hematology Oncology Transplantation, University of Minnesota, 420 Delaware Street, S E, MMC 480, Minneapolis, MN 55455, USA
    Breast Cancer Res Treat 122:585-90. 2010
    ..Although not statistically significant, this study suggests that the use of ACE-I when given with DOX chemotherapy protects against DOX chemotherapy and warrants further investigation...
  7. ncbi Monitoring and preemptive rituximab therapy for Epstein-Barr virus reactivation after antithymocyte globulin containing nonmyeloablative conditioning for umbilical cord blood transplantation
    Anne H Blaes
    University of Minnesota Blood and Marrow Transplant Program, Minneapolis, Minnesota, USA
    Biol Blood Marrow Transplant 16:287-91. 2010
    ....
  8. ncbi Malassezia: is it a pulmonary pathogen in the stem cell transplant population?
    A H Blaes
    Division of Hematology Oncology Transplantation, Veterans Affairs Medical Center, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Transpl Infect Dis 11:313-7. 2009
    ..The clinical characteristics of these patients, the infections, treatment, and outcome are described. In addition, we discuss the possible pathogenicity of this yeast in the pulmonary setting...
  9. ncbi Necrotizing leukoencephalopathy following CHOP chemotherapy
    Anne H Blaes
    University of Minnesota, Department of Medicine, Division of Hematology Oncology Transplantation, United States
    Leuk Res 32:1611-4. 2008
    ..There has been one case of fatal leukoencephalopathy reported following CHOP chemotherapy for non-Hodgkin lymphoma. We report a second case of fatal necrotizing leukoencephalopathy following the administration of CHOP chemotherapy...
  10. ncbi Quality of life appears similar between survivors of indolent and aggressive non-Hodgkin lymphoma
    Anne H Blaes
    Division of Hematology Oncology Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA
    Leuk Lymphoma 52:2105-10. 2011
    ..Our study reports a similar overall QOL between survivors of IND and AGG NHL. Physical function, however, may be more impaired in survivors of AGG NHL...